Terasaki Biomedical
Maurizio Vecchione
From his LinkedIn:
I am focused on driving high impact solution to help improve the health of the planet and of all humans on it. I believe that solving some of the world’s biggest problems unlocks some of the greatest opportunities. I am an advocate for climate and health innovation, health equity, an impact fund leader, and a global transformation architect.
My career spans over 30 years at the forefront of climate tech, global and public health, focusing on innovation to improve the lives of the world’s most vulnerable people. I am the Chief Innovation Officer of the Terasaki Institute for Biomedical Innovation, a non profit where I am helping a strategy for translation of breakthrough technologies in life sciences and bio-medicine, for planetary health and human health. I am also jointly appointed at the non-profit Washington Global Health Alliance, an alliance that federates the leading organizations working to achieve global health equity. I am also the President of Openwater, an early stage company pioneering new modalities for stroke care and prevention as well as neuroscience and neurodegenerative disease.
I am an investor in life sciences and advise multiple venture and private equity funds, especially around impact investing, including as a Partner at Ethos Capital and at Adastral Funds.
Previously I led Global Good Fund, the collaboration between Bill Gates and Intellectual Ventures to invent and deploy technology specifically focused on improving life in developing countries, I have been at the forefront of research & development and commercialization of novel cancer screening digital health technologies, novel in-vitro diagnostics, disruptive biotechnology and medical devices as well as in the use of data science for predictive analytics in disease epidemiology and bioinformatics. I have pioneered new models for reverse innovation and private sector investment in impact innovation which I have executed with companies and governments around the world.
I also serve on the Board of the UCLA Ronald Regan Medical Center, the University of Washington Department of Global Health, the Italian Scientists and Scholars of North America Foundation (ISSNAF) and as the Pacific Leadership Fellow at the University of California, San Diego.
Recent Comments